Clinical Trial Update: Safety and Tolerability Study of 131I-TM-601 to Treat Adult Patients With Recurrent Glioma. [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 safety and tolerability study of the radiopharmaceutical 131I-TM-601 in adults with recurrent glioma has completed; the update summarizes safety and t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioma

Drugs mentioned

• 131I-TM-601

Snippet

Sponsor: TransMolecular | Conditions: Glioma, Brain Neoplasm | Phase 1, Phase 2 | Status: COMPLETED